AXIM Biotechnologies' Development of Rapid Test for COVID-19 Neutralizing Antibodies is Cited to Demonstrate over 90% Sensitivity and 100% Specificity
Stock Information for Axim Biotechnologies Inc
Loading
Please wait while we load your information from QuoteMedia.